Ajinomoto Co Inc (2802)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Ajinomoto Co Inc (2802) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013429
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ajinomoto Co Inc (Ajinomoto) is a food products company that focuses on foods, bioscience fine chemicals and pharmaceuticals and health. It carries out research and development and production of seasonings, processed foods, beverages, amino acids, pharmaceuticals and specialty chemicals. The company also provides solutions for improved food resources, human health and global sustainability. Ajinomoto is also involved in wellness, packaging, logistics, and other services. The company has operations in Europe, Africa, Japan, Asia and Americas. Ajinomoto is headquartered in Tokyo, Japan.

Ajinomoto Co Inc (2802) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Ajinomoto Co Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Ajinomoto Co Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Ajinomoto Co Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Ajinomoto Co Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Ajinomoto Co Inc, Medical Devices Deals, 2011 to YTD 2017 9
Ajinomoto Co Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Ajinomoto Co Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Eisai Forms Joint Venture with Ajinomoto 11
Althea Technologies Enters Into Co-Marketing Agreement With Sherpa Clinical 12
Licensing Agreements 13
Allena Pharma Amends Licensing Agreement With Althea Technologies 13
Ajinomoto North America Enters Into Licensing Agreement With Global Pharma Company For Corynex 14
Acquisition 15
Ajinomoto to Acquire GeneDesign 15
Ajinomoto Completes Acquisition Of Althea Technologies For US$175 Million 16
Ajinomoto Co Inc – Key Competitors 18
Ajinomoto Co Inc – Key Employees 19
Ajinomoto Co Inc – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Joint Venture 23
Recent Developments 24
Other Significant Developments 24
Apr 13, 2017: Ajinomoto OmniChem Launches Flow Chemistry for API Commercial Manufacturing 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Ajinomoto Co Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Ajinomoto Co Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Ajinomoto Co Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Ajinomoto Co Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Ajinomoto Co Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Ajinomoto Co Inc, Medical Devices Deals, 2011 to YTD 2017 9
Ajinomoto Co Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Eisai Forms Joint Venture with Ajinomoto 11
Althea Technologies Enters Into Co-Marketing Agreement With Sherpa Clinical 12
Allena Pharma Amends Licensing Agreement With Althea Technologies 13
Ajinomoto North America Enters Into Licensing Agreement With Global Pharma Company For Corynex 14
Ajinomoto to Acquire GeneDesign 15
Ajinomoto Completes Acquisition Of Althea Technologies For US$175 Million 16
Ajinomoto Co Inc, Key Competitors 18
Ajinomoto Co Inc, Key Employees 19
Ajinomoto Co Inc, Subsidiaries 21
Ajinomoto Co Inc, Joint Venture 23

★海外企業調査レポート[Ajinomoto Co Inc (2802)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ShotSpotter Inc (SSTI):企業の財務・戦略的SWOT分析
    ShotSpotter Inc (SSTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Capita plc:企業の戦略・SWOT・財務分析
    Capita plc - Strategy, SWOT and Corporate Finance Report Summary Capita plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Korea Gas Corp (036460):石油・ガス:M&Aディール及び事業提携情報
    Summary Korea Gas Corp (KOGAS) is a vertically integrated natural gas company active in upstream midstream and downstream segments of natural gas industry. It explores, produces and distributes natural gas. The company also purifies and sells by-products; imports and exports natural gas and liquefie …
  • Catabasis Pharmaceuticals Inc (CATB):企業の財務・戦略的SWOT分析
    Summary Catabasis Pharmaceuticals Inc (Catabasis Pharmaceuticals) is a clinical-stage biopharmaceutical company that discovers, develops and commercializes medicines for the treatment of multiple diseases. The company develops its product candidates using its proprietary safely metabolized and ratio …
  • FANUC CORPORATION:企業の戦略・SWOT・財務情報
    FANUC CORPORATION - Strategy, SWOT and Corporate Finance Report Summary FANUC CORPORATION - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • MITIE Group plc (MTO):企業の財務・戦略的SWOT分析
    MITIE Group plc (MTO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Exact Imaging Inc:医療機器:M&Aディール及び事業提携情報
    Summary Exact Imaging Inc (Exact Imaging) formerly Imagistx Inc, is a provider of high-resolution micro-ultrasound systems enabling real-time imaging and guided biopsies for prostate cancer analysis. The company’s ExactVu micro-ultrasound platform operates high resolution conventional and biopsy tra …
  • SoftBank Group Corp. (Formerly SoftBank Corp.):戦略・SWOT・企業財務分析
    SoftBank Group Corp. (Formerly SoftBank Corp.) - Strategy, SWOT and Corporate Finance Report Summary SoftBank Group Corp. (Formerly SoftBank Corp.) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • Banco Santander (Brasil) SA:企業の戦略・SWOT・財務情報
    Banco Santander (Brasil) SA - Strategy, SWOT and Corporate Finance Report Summary Banco Santander (Brasil) SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Precision Biologics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Precision Biologics Inc (PBI), a subsidiary of NantWorks LLC, is a clinical stage biotechnology company. The company offers cancer vaccines, antigens and antibodies, pipelines, diagnostics, therapeutics, clinical trials, tumor specific antigens, companion diagnostic programs, and diagnostic …
  • IHI Aerospace Co Ltd:企業の戦略・SWOT・財務情報
    IHI Aerospace Co Ltd - Strategy, SWOT and Corporate Finance Report Summary IHI Aerospace Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Human Longevity Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Human Longevity Inc (HLI) is a genomics-based technology company that develops sequenced genomes and phenotypic database. The company’s discovery capabilities include streamlining drug development, rescuing and repurposing drugs from failed clinical trials and discovery of biomarker and comp …
  • Akbank TAS (AKBNK):企業の財務・戦略的SWOT分析
    Akbank TAS (AKBNK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Fulgent Genetics Inc (FLGT):企業の財務・戦略的SWOT分析
    Fulgent Genetics Inc (FLGT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • RWE AG (RWE):企業の財務・戦略的SWOT分析
    RWE AG (RWE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • YTL Power International Bhd (YTLPOWR):企業の財務・戦略的SWOT分析
    YTL Power International Bhd (YTLPOWR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Nexstar Media Group, Inc. (NXST):企業の財務・戦略的SWOT分析
    Nexstar Media Group, Inc. (NXST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Groupama Assurances Mutuelles:企業の戦略的SWOT分析
    Groupama Assurances Mutuelles - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Akari Therapeutics Plc (AKTX):製薬・医療:M&Aディール及び事業提携情報
    Summary Akari Therapeutics Plc (Akari), formerly Celsus Therapeutics Plc is a biopharmaceutical company that develops treatments for rare and orphan autoimmune and inflammatory diseases. The company offers coversin drugs that act on complement component-C5 that helps in preventing the release of C5a …
  • Range Resources Corp (RRC):石油・ガス:M&Aディール及び事業提携情報
    Summary Range Resources Corp (Range) is independent oil, natural gas and natural gas liquids (NGL) company that explores, develops, and acquires natural gas and oil properties in the US. It has oil and gas properties in the Appalachian basin and Northern Louisiana of the US. Range’s natural gas and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆